VICTORIS
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
Loans
Loans

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • MCX India has target of Rs 938: SP Tulsian

    MCX India has target of Rs 938: SP Tulsian

    MCX India has target of Rs 938, says SP Tulsian of sptulsian.com.

  • SP Tulsian picks 5 midcap ideas for 2013

    SP Tulsian picks 5 midcap ideas for 2013

    On CNBC-TV18's Investor camp, SP Tulsian of sptulsian.com picked five stocks from the midcap space which should be on investor's radar till elections get announced (March or early 2014).

  • Buy MCX India, ABG Shipyard; Sell Renuka Sugars: Tulsian

    Buy MCX India, ABG Shipyard; Sell Renuka Sugars: Tulsian

    In CNBC-TV18's popular show Bull's Eye, SP Tulsian of sptulsian.com shares trading strategy of the day.

  • Bull's Eye: Short IFCI, IVRCL, Yes Bank; buy MCX

    Bull's Eye: Short IFCI, IVRCL, Yes Bank; buy MCX

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Check out: Trading ideas by 3 market experts

    Check out: Trading ideas by 3 market experts

    In an interview to CNBC-TV18, Sudarshan Sukhani of s2analytics.com, SP Tulsian of sptulsian.com and Hemant Thukral of Aditya Birla Money give top pick for the day.

  • HUL can touch Rs 480-485: Kulkarni

    HUL can touch Rs 480-485: Kulkarni

    Shardul Kulkarni, Angel Broking is of the view that HUL can touch Rs 480-485. One can buy MCX India at current level.

  • SP Tulsian bets on two stocks for 20-27% returns

    SP Tulsian bets on two stocks for 20-27% returns

    In an interview to CNBC-TV18, SP Tulsian of sptulsian.com picks two stocks as his multi-baggers for the day. Tulsian bets on MCX and APL Apollo Tubes. He predicts MCX India's target price to be Rs 1,250 and APL Apollo Tubes' target price to be Rs 225 in the next six months.

  • MCX can move to Rs 1250, says SP Tulsian

    MCX can move to Rs 1250, says SP Tulsian

    SP Tulsian, sptulsian.com feels that Multi Commodity Exchange of India (MCX) can move to Rs 1,250 in about six months. They have a commodity exchange which enjoys 85 percent of the market share plus presence in about 1,600 cities with 3.5 lakh terminals and 2,200 members, he adds.

  • Buy MCX below Rs 1000: SP Tulsian

    Buy MCX below Rs 1000: SP Tulsian

    Buy Multi Commodity Exchange of India (MCX) below Rs 1000, says SP Tulsian, sptulsian.com.

  • MCX India may see limited weakness, says SP Tulsian

    MCX India may see limited weakness, says SP Tulsian

    MCX India may see limited weakness from hereon, says SP Tulsian, sptulsian.com.

  • Biz of MCX continues to be good for long term: Sekhar

    Biz of MCX continues to be good for long term: Sekhar

    Phani Sekhar, Fund Manager of Angel Broking feels the business of MCX continues to be good from a very long-term perspective.

  • MCX will see much lower levels in 2013: Sukhani

    MCX will see much lower levels in 2013: Sukhani

    Sudarshan Sukhani of s2analytics.com feels MCX will see much lower levels during this year. According to him, it is a selling opportunity.

  • MCX India looks good: SP Tulsian

    MCX India looks good: SP Tulsian

    MCX India is looking good around Rs 1050, says SP Tulsian, sptulsian.com.

  • MCX may correct 4-5%: SP Tulsian

    MCX may correct 4-5%: SP Tulsian

    SP Tulsian, sptulsian.com feels that Multi Commodity Exchange of India (MCX) may correct 4-5 percent.

  • Buy MCX India, Sun TV; sell Jain Irrigation: Parag Doctor

    Buy MCX India, Sun TV; sell Jain Irrigation: Parag Doctor

    In CNBC-TV18's popular show Bull's Eye, Parag Doctor of Keynote Capital shares trading strategy of the day.

  • Bull's eye: Buy MCX, Mercator; short OBC, Andhra Bank

    Bull's eye: Buy MCX, Mercator; short OBC, Andhra Bank

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • MCX, Financial Tech can give 5-7% returns: SP Tulsian

    MCX, Financial Tech can give 5-7% returns: SP Tulsian

    SP Tulsian, sptulsian.com feels that Multi Commodity Exchange of India (MCX) and Financial Technologies can give 5 -7% returns.

  • Buy Aurobindo Pharma, SPARC, MCX India: ITI Wealth

    Buy Aurobindo Pharma, SPARC, MCX India: ITI Wealth

    Lancelot D Cunha of ITI Wealth Management is bullish on Aurobindo Pharma, SPARC and MCX India, advising buying these stocks.

  • Bet on top six stocks for December 21

    Bet on top six stocks for December 21

    On CNBC-TV18's show Super Six, market gurus Shardul Kulkarni of Angel Broking, Arunesh Madan of Augment Investment and Rajesh Jain of Religare Sec, place their bets on two stocks each, thus offering investors a variety of options to choose from.

  • Bull's eye: Buy NCC, MCX, Canara Bank, short Karnataka Bank

    Bull's eye: Buy NCC, MCX, Canara Bank, short Karnataka Bank

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Buy Shasun Pharma, MCX India, Ceat: Joshi

    Buy Shasun Pharma, MCX India, Ceat: Joshi

    In CNBC-TV18's popular show Bull's Eye, Sharmila Joshi of sharmilajoshi.com shares trading strategy of the day.

  • Bull's Eye: Buy Thomas Cook, MCX, SKS Micro, KRBL

    Bull's Eye: Buy Thomas Cook, MCX, SKS Micro, KRBL

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Buy Anant Raj Ind, Karnataka Bank, Pantaloon Retail: Doctor

    Buy Anant Raj Ind, Karnataka Bank, Pantaloon Retail: Doctor

    In CNBC-TV18's popular show Bull's Eye, Parag Doctor of Keynote Capital shares trading strategy of the day.

  • Bull's Eye: Buy MCX, Cipla, Dhanlaxmi Bank, Short DLF

    Bull's Eye: Buy MCX, Cipla, Dhanlaxmi Bank, Short DLF

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Buy SBI around Rs 2060, says Baliga

    Buy SBI around Rs 2060, says Baliga

    Ambareesh Baliga, Market Expert advice traders to buy SBI around Rs 2060.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347